- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05102435
Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Cross-cultural Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Among older persons, age-related impairments cause loss of postural control and balance that result in pain, independency and disability. One of the most common geriatric syndromes and most serious health issue threatening the independency of older persons is fall. The impact of these fall-related injuries on older person, families and societies and its fruitful intervention has made this issue important worldwide. Approximately 28-35% of people aged 65 years and 32-42% of aged 70 years' experience falls annually and 10% suffer serious injury such as, fracture, severe head trauma and joint dislocation. The incidence rate of fall is higher in hospitalized and residents of nursing home. It rises from middle age and peaks in person above 80 years. The risk factors associated with falls are, lower extremity muscle weakness, gait or balance deficits, use of an assistive device, cognitive impairment, visual deficit, arthritis and impaired activities of daily living . Different scales and tests are used for risk factors for falls, balance and mobility such as Berg Balance Scale, Time up and go test and dynamic gait index and Fullerton Advanced Balance Scale. One of these scales Performance-Oriented Mobility Assessment (POMA) scale. POMA scale has acceptable reliability and validity as compared to FRT and TUG in elderly. The advantages of this scale are; applicability, low cost, easy to administer, no equipment is needed other than a standard chair and stopwatch, evaluates functional activities and assesses both balance (POMA-B) and gait components (POMA-G)Originally POMA scale was used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and determine effects of interventions.
The POMA has found to be widely used in patients who have dynamic and reactive balance deficits. It comprises 16 items (9 balance and 7 gait related). Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score. Some Items are scored dichotomously (can/cannot perform) and others are scored 0, 1 or 2 points for quality of performance. The higher scores show low fall risk and better balance while lower score predicts poorer balance and greater risk of fall. The score 19-24/28 indicates moderate risk for falling while score <19 indicates a "high" risk for falling.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Rawalpindi, Pakistan, 46000
- Misbah Ghous
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- The sample will be assessed a cognition evaluation through the mini-mental test
- Any present or previous history of vertigo since last 6 months
Exclusion Criteria:
- Patients with any neurological disorder,
- previous orthopedic surgery within last 6 months,
- bedridden,
- wearing any prosthesis, and illiteracy.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Performance oriented mobility Assessment scale
Délai: 1 time assessment of mobility and balance (approximately 10 minutes)
|
Performance oriented mobility Assessment scale is used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and balance assessment.
Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score
|
1 time assessment of mobility and balance (approximately 10 minutes)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Misbah ghous, MS, Riphah International University Islamabad
Publications et liens utiles
Publications générales
- Yücel SD, Şahin F, Doğu B, Şahin T, Kuran B, Gürsakal S. Reliability and validity of the Turkish version of the Performance-Oriented Mobility Assessment I. European Review of Aging and Physical Activity. 2012 Oct;9(2):149-59.
- Schulein S, Pflugrad L, Petersen H, Lutz M, Volland-Schussel K, Gassmann KG. [German translation of the performance-oriented mobility assessment according to Tinetti]. Z Gerontol Geriatr. 2017 Aug;50(6):498-505. doi: 10.1007/s00391-016-1070-9. Epub 2016 Jun 16. German.
- Moulodi B, Azad A, Taghizadeh G, Roohi-Azizi M, Mohammadi P. Reliability and validity of persian version of performance-oriented mobility assessment (POMA) in Community-dwelling Iranian Older Adults: Psychometric Properties. Iranian Rehabilitation Journal. 2020;18(1):39-48.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- REC/00964 Kiran
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .